Literature DB >> 27798747

Validity and reliability of the Greek version of the xerostomia questionnaire in head and neck cancer patients.

Pinelopi Theopisti Memtsa1, Maria Tolia2, Ioannis Tzitzikas3, Ioannis Bizakis4, Kyriaki Pistevou-Gombaki3, Martha Charalambidou5, Chrysoula Iliopoulou5, George Kyrgias2.   

Abstract

PURPOSE: Xerostomia after radiation therapy for head and neck (H&N) cancer has serious effects on patients' quality of life. The purpose of this study was to validate the Greek version of the self-reported eight-item xerostomia questionnaire (XQ) in patients treated with radiotherapy for H&N cancer.
METHODS: The XQ was translated into Greek and administered to 100 XQ patients. An exploratory factor analysis was performed. Reliability measures were calculated. Several types of validity were evaluated. The observer-rated scoring system was also used.
RESULTS: The mean XQ value was 41.92 (SD 22.71). Factor analysis revealed the unidimensional nature of the questionnaire. High reliability measures (ICC, Cronbach's α, Pearson coefficients) were obtained. Patients differed statistically significantly in terms of XQ score, depending on the RTOG/EORTC classification.
CONCLUSION: The Greek version of XQ is valid and reliable. Its score is well related to observer's findings and it can be used to evaluate the impact of radiation therapy on the subjective feeling of xerostomia.

Entities:  

Keywords:  Head and neck cancer; Quality of life; Questionnaire; Radiotherapy; Reliability; Validity; Xerostomia

Mesh:

Year:  2016        PMID: 27798747     DOI: 10.1007/s00520-016-3471-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  16 in total

Review 1.  Assessment of post-radiotherapy salivary glands.

Authors:  S C H Cheng; V W C Wu; D L W Kwong; M T C Ying
Journal:  Br J Radiol       Date:  2011-05       Impact factor: 3.039

Review 2.  Quality of life tools in head and neck oncology.

Authors:  N Heutte; L Plisson; M Lange; V Prevost; E Babin
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2013-11-28       Impact factor: 2.080

3.  Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.

Authors:  Michael Little; Matthew Schipper; Felix Y Feng; Karen Vineberg; Craig Cornwall; Carol-Anne Murdoch-Kinch; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-04       Impact factor: 7.038

4.  Subjective reports of xerostomia and objective measures of salivary gland performance.

Authors:  P C Fox; K A Busch; B J Baum
Journal:  J Am Dent Assoc       Date:  1987-10       Impact factor: 3.634

5.  Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.

Authors:  Amichay Meirovitz; Carol Anne Murdoch-Kinch; Mathew Schipper; Charlie Pan; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-12       Impact factor: 7.038

6.  Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.

Authors:  A Eisbruch; H M Kim; J E Terrell; L H Marsh; L A Dawson; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-01       Impact factor: 7.038

7.  Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.

Authors:  Siavash Jabbari; Hyungjin M Kim; Mary Feng; Alexander Lin; Christina Tsien; Mohamed Elshaikh; Jeffrey E Terrel; Carol Murdoch-Kinch; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-01       Impact factor: 7.038

8.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.

Authors:  Johannes A Langendijk; Patricia Doornaert; Irma M Verdonck-de Leeuw; Charles R Leemans; Neil K Aaronson; Ben J Slotman
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

9.  Longitudinal quality of life in Turkish patients with head and neck cancer undergoing radiotherapy.

Authors:  Esra Citak; Zeliha Tulek
Journal:  Support Care Cancer       Date:  2013-03-09       Impact factor: 3.603

10.  Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy.

Authors:  A B Miah; S L Gulliford; J Morden; K L Newbold; S A Bhide; S H Zaidi; E Hall; K J Harrington; C M Nutting
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-03-17       Impact factor: 4.126

View more
  4 in total

1.  Validity and reliability of the Greek version of the xerostomia questionnaire in head and neck cancer patients: methodological issues to avoid misinterpretation.

Authors:  Saeid Safiri; Erfan Ayubi
Journal:  Support Care Cancer       Date:  2017-01-21       Impact factor: 3.603

2.  Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiation therapy.

Authors:  Pinelopi-Theopisti Memtsa; Maria Tolia; Ioannis Tzitzikas; John Bizakis; Kyriaki Pistevou-Gombaki; Martha Charalambidou; Chrysoula Iliopoulou; George Kyrgias
Journal:  Mol Clin Oncol       Date:  2017-03-17

3.  A prospective study of patient-reported xerostomia-related outcomes after parotidectomy.

Authors:  Kara D Brodie; Aaron L Zebolsky; Edgar Ochoa; Patrick K Ha; Chase M Heaton; Ivan H El-Sayed; William R Ryan
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-05-29

Review 4.  Diagnosis, Prevention, and Treatment of Radiotherapy-Induced Xerostomia: A Review.

Authors:  Yanli Li; Xuehan Li; Runxuan Pang; Guang Yang; Mingxu Tian; Tengyu Zhao; Yunhan Sun; Eui-Seok Lee; Heng Bo Jiang; Jianmin Han
Journal:  J Oncol       Date:  2022-08-27       Impact factor: 4.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.